wnt/beta-catenin signaling pathway inhibitors (Tonix Pharmaceuticals)

N/A

Report date: 2025/01/26 17:07:38
NME

Base Information

Drug Namewnt/beta-catenin signaling pathway inhibitors (Tonix Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 degradersWingless type MMTV integration site family protein inhibitors
TargetsCatenin beta 1Wingless type MMTV integration site family protein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTonix Pharmaceuticals Holding Corp
China Registration ClassN/A

Develop Information

Active CompaniesTonix Pharmaceuticals Holding Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A